Home » Topics » Conferences

Conferences
RSS

Tacrolimus may represent novel neurotrophic strategy for neurodegenerative disorders

Oct. 30, 1998

Kappa-opioid antagonist MR-2266 is also an antagonist of ORL1 receptors

Oct. 30, 1998

AChE inhibition does not contribute to the neuroprotective effects of anseculin in vivo

Oct. 29, 1998

Alpha2-adrenoceptor antagonists useful as adjuncts to L-DOPA in PD

Oct. 28, 1998

Melagatran in different vehicles compared in rat model of thrombosis

Oct. 28, 1998

Clinical, preclinical efficacy of Neovastat featured at recent congress

Oct. 27, 1998

Pharmacokinetic and therapeutic equivalence of Zelapar and Eldepryl

Oct. 27, 1998

Apotex conducting early studies on oral chelating agents

Oct. 27, 1998

RPR presents clinical findings with gpIIb/IIIa antagonist; product dropped due to dosing problems

Oct. 27, 1998

Sublingual apomorphine safe and effective in PD patients with motor fluctuations

Oct. 26, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...